GlassScriptPhysician profile
Morgan Ashley Thomas
NPI 1063936474
$6,087.02
in general payments reported to CMS, 2019-2025
38 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,544 · 2022: $1,074 · 2023: $1,341 · 2024: $1,032 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,469.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,329.23 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $633.10 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $490.25 | 2021-2025 | Trintellix |
| Lilly USA, LLC | $488.04 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $482.23 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $433.78 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $286.34 | 2021-2025 | |
| Abbott Laboratories | $216.91 | 2021-2025 | Freestyle Libre, Proclaim |
| Janssen Pharmaceuticals, INC | $168.54 | 2021-2024 | Spravato |
| Corcept Therapeutics | $145.30 | 2021-2025 | Korlym |
| Exact Sciences Corporation | $137.65 | 2023-2025 | Cologuard Collection Kit |
| Lundbeck LLC | $115.17 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $91.97 | 2022 | |
| Phathom Pharmaceuticals, INC. | $89.09 | 2024-2025 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $85.83 | 2021-2023 | Livalo, Seglentis |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $83.53 | 2021-2022 | |
| Dexcom, INC. | $78.10 | 2022-2025 | Dexcom G6 Transmitter |
| Eisai INC. | $75.18 | 2021-2024 | |
| Glaxosmithkline, LLC. | $67.98 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Xeris Pharmaceuticals, INC. | $67.81 | 2022-2025 | Gvoke Hypopen |
| Astellas Pharma US INC | $54.55 | 2021-2025 | Veozah |
| Idorsia Pharmaceuticals US INC | $50.71 | 2023 | Quviviq |
| Renalytix Ai, INC. | $50.43 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Paratek Pharmaceuticals, INC. | $43.93 | 2025 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $42.78 | 2022-2024 | |
| Tris Pharma INC | $38.98 | 2023 | Dyanavel Xr |
| Ibsa Pharma INC. | $28.46 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $26.66 | 2021 | |
| Merck Sharp & Dohme LLC | $26.31 | 2021 | |
| Acclarent, INC | $25.83 | 2023 | Relieva Spinplus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.96 | 2023 | |
| Allergan, INC. | $19.94 | 2021 | |
| Adlon Therapeutics L.P. | $18.67 | 2021 | |
| Mylan Specialty L.P. | $18.32 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.36 | 2023 | |
| Antares Pharma, INC. | $13.13 | 2023 | Xyosted, Tlando, Nocdurna |
| Novartis Pharmaceuticals Corporation | $12.59 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.